Agriflu

Vaccine: Agriflu
Company: Novartis
Approval Date: Oct. 24
Protects Against: Influenza

Novartis' ($NVS) Agriflu had a rough start to the 2012-2013 flu season. Switzerland, Canada, Italy and several other European countries banned the vaccine in October due to the discovery by the company of small clumps of virus particles in some batches. About 488,000 doses were affected by the ban. Novartis pulled the vaccine as drug regulators determined whether it was safe. The countries eventually lifted the ban and Novartis went on its merry way distributing the vaccine. The FDA approved Agriflu a bit later than many of the other flu vaccines, giving it the go-ahead Oct. 24.

For more:
Canada, Switzerland lift ban on Novartis flu vaccine
Canada joins in on Novartis vaccine suspension
Germany, France join crowd withdrawing Novartis vaccines
Under regulatory cloud, CEO says Novartis must boost quality

Agriflu
Read more on

Suggested Articles

Sanofi lost an appeal challenging the ban on its dengue vaccine Dengvaxia in the Philippines, despite an ongoing outbreak there.

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.

Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.